316 related articles for article (PubMed ID: 27039906)
1. Periostin promotes hepatic fibrosis in mice by modulating hepatic stellate cell activation via α
Sugiyama A; Kanno K; Nishimichi N; Ohta S; Ono J; Conway SJ; Izuhara K; Yokosaki Y; Tazuma S
J Gastroenterol; 2016 Dec; 51(12):1161-1174. PubMed ID: 27039906
[TBL] [Abstract][Full Text] [Related]
2. Matricellular protein periostin contributes to hepatic inflammation and fibrosis.
Huang Y; Liu W; Xiao H; Maitikabili A; Lin Q; Wu T; Huang Z; Liu F; Luo Q; Ouyang G
Am J Pathol; 2015 Mar; 185(3):786-97. PubMed ID: 25541330
[TBL] [Abstract][Full Text] [Related]
3. Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells.
Kumar P; Smith T; Raeman R; Chopyk DM; Brink H; Liu Y; Sulchek T; Anania FA
J Biol Chem; 2018 Aug; 293(33):12781-12792. PubMed ID: 29941453
[TBL] [Abstract][Full Text] [Related]
4. Periostin down-regulation attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
Hong L; Shejiao D; Fenrong C; Gang Z; Lei D
J Cell Mol Med; 2015 Oct; 19(10):2462-8. PubMed ID: 26249143
[TBL] [Abstract][Full Text] [Related]
5. CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.
Mejias M; Gallego J; Naranjo-Suarez S; Ramirez M; Pell N; Manzano A; Suñer C; Bartrons R; Mendez R; Fernandez M
Gastroenterology; 2020 Jul; 159(1):273-288. PubMed ID: 32169429
[TBL] [Abstract][Full Text] [Related]
6. Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma.
Yang L; Serada S; Fujimoto M; Terao M; Kotobuki Y; Kitaba S; Matsui S; Kudo A; Naka T; Murota H; Katayama I
PLoS One; 2012; 7(7):e41994. PubMed ID: 22911870
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.
Olsen AL; Sackey BK; Marcinkiewicz C; Boettiger D; Wells RG
Gastroenterology; 2012 Apr; 142(4):928-937.e3. PubMed ID: 22202457
[TBL] [Abstract][Full Text] [Related]
8. Loss of Sept4 exacerbates liver fibrosis through the dysregulation of hepatic stellate cells.
Iwaisako K; Hatano E; Taura K; Nakajima A; Tada M; Seo S; Tamaki N; Sato F; Ikai I; Uemoto S; Kinoshita M
J Hepatol; 2008 Nov; 49(5):768-78. PubMed ID: 18804890
[TBL] [Abstract][Full Text] [Related]
9. Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis.
Cui G; Chen J; Wu Z; Huang H; Wang L; Liang Y; Zeng P; Yang J; Uede T; Diao H
J Cell Physiol; 2019 Jun; 234(6):8988-8997. PubMed ID: 30350863
[TBL] [Abstract][Full Text] [Related]
10. Activation of Slit2-Robo1 signaling promotes liver fibrosis.
Chang J; Lan T; Li C; Ji X; Zheng L; Gou H; Ou Y; Wu T; Qi C; Zhang Q; Li J; Gu Q; Wen D; Cao L; Qiao L; Ding Y; Wang L
J Hepatol; 2015 Dec; 63(6):1413-20. PubMed ID: 26264936
[TBL] [Abstract][Full Text] [Related]
11. Deficiency in augmenter of liver regeneration accelerates liver fibrosis by promoting migration of hepatic stellate cell.
Ai WL; Dong LY; Wang J; Li ZW; Wang X; Gao J; Wu Y; An W
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3780-3791. PubMed ID: 30251695
[TBL] [Abstract][Full Text] [Related]
12. A novel biphenyl compound IMB-S7 ameliorates hepatic fibrosis in BDL rats by suppressing Sp1-mediated integrin αv expression.
Zhang N; Zhao SS; Zhang YX; Wang YC; Shao RG; Wang JX; He HW
Acta Pharmacol Sin; 2020 May; 41(5):661-669. PubMed ID: 31932644
[TBL] [Abstract][Full Text] [Related]
13. Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice.
Senoo T; Sasaki R; Akazawa Y; Ichikawa T; Miuma S; Miyaaki H; Taura N; Nakao K
BMC Gastroenterol; 2018 Feb; 18(1):34. PubMed ID: 29486718
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression.
Ma L; Yang X; Wei R; Ye T; Zhou JK; Wen M; Men R; Li P; Dong B; Liu L; Fu X; Xu H; Aqeilan RI; Wei YQ; Yang L; Peng Y
Cell Death Dis; 2018 Jun; 9(7):718. PubMed ID: 29915227
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging of hepatic stellate cell activity by visualization of hepatic integrin αvβ3 expression with SPECT in rat.
Li F; Song Z; Li Q; Wu J; Wang J; Xie C; Tu C; Wang J; Huang X; Lu W
Hepatology; 2011 Sep; 54(3):1020-30. PubMed ID: 21618580
[TBL] [Abstract][Full Text] [Related]
16. Activated hepatic stellate cell-derived Bmp-1 induces liver fibrosis via mediating hepatocyte epithelial-mesenchymal transition.
Wan S; Liu X; Sun R; Liu H; Jiang J; Wu B
Cell Death Dis; 2024 Jan; 15(1):41. PubMed ID: 38216590
[TBL] [Abstract][Full Text] [Related]
17. Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non-alcoholic steatohepatitis.
Kobayashi T; Kanno K; Nguyen PT; Sugiyama A; Kawahara A; Otani Y; Kishikawa N; Ito M; Tazuma S
J Gastroenterol Hepatol; 2020 Dec; 35(12):2140-2150. PubMed ID: 32365405
[TBL] [Abstract][Full Text] [Related]
18. The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor.
Avraham Y; Amer J; Doron S; Abu-Tair L; Mahamid M; Khatib A; Berry EM; Safadi R
Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(12):G1364-72. PubMed ID: 22517772
[TBL] [Abstract][Full Text] [Related]
19. Periostin cross‑reacts with the renin‑angiotensin system during liver fibrosis development.
Takeda K; Noguchi R; Kitade M; Namisaki T; Moriya K; Kawaratani H; Okura Y; Kaji K; Aihara Y; Douhara A; Nishimura N; Sawada Y; Seki K; Yoshiji H
Mol Med Rep; 2017 Nov; 16(5):5752-5758. PubMed ID: 28849131
[TBL] [Abstract][Full Text] [Related]
20. SIRT1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice.
Li M; Hong W; Hao C; Li L; Wu D; Shen A; Lu J; Zheng Y; Li P; Xu Y
FASEB J; 2018 Jan; 32(1):500-511. PubMed ID: 28970250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]